These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11204147)

  • 1. Cryptococcosis: clinical and biological aspects.
    Kwon-Chung KJ; Sorrell TC; Dromer F; Fung E; Levitz SM
    Med Mycol; 2000; 38 Suppl 1():205-13. PubMed ID: 11204147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.
    Chen S; Sorrell T; Nimmo G; Speed B; Currie B; Ellis D; Marriott D; Pfeiffer T; Parr D; Byth K
    Clin Infect Dis; 2000 Aug; 31(2):499-508. PubMed ID: 10987712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.
    Davis JA; Horn DL; Marr KA; Fishman JA
    Transpl Infect Dis; 2009 Oct; 11(5):432-7. PubMed ID: 19638005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.
    Lin TY; Yeh KM; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2009 Jun; 42(3):220-6. PubMed ID: 19812855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
    Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
    Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of Cryptococcus neoformans strains isolated from patients with acquired immunodeficiency syndrome (AIDS)].
    Garza-Garza D; Buendía-Uribe JL; Martínez-Cruz E; Argüero-Licea B
    Rev Latinoam Microbiol; 1995; 37(3):273-9. PubMed ID: 8850346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms.
    Rodrigues ML; Alviano CS; Travassos LR
    Microbes Infect; 1999 Apr; 1(4):293-301. PubMed ID: 10602663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
    Mitchell TG; Perfect JR
    Clin Microbiol Rev; 1995 Oct; 8(4):515-48. PubMed ID: 8665468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cryptococcus neoformans genome sequencing project.
    Heitman J; Casadevall A; Lodge JK; Perfect JR
    Mycopathologia; 1999; 148(1):1-7. PubMed ID: 11086479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in cryptococcosis, candidiasis and coccidioidomycosis complicating HIV infection.
    Kappe R; Levitz S; Harrison TS; Ruhnke M; Ampel NM; Just-Nübling G
    Med Mycol; 1998; 36 Suppl 1():207-15. PubMed ID: 9988509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tests for an early detection of pulmonary cryptococcosis by sputum culture].
    Mukamurangwa P; Bogaerts J; Taelman H; Batungwanayo J; Kagame A; van de Perre P; Swinne D
    Bull Soc Pathol Exot; 1994; 87(1):41-4. PubMed ID: 8003904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus.
    Li SS; Mody CH
    Proc Am Thorac Soc; 2010 May; 7(3):186-96. PubMed ID: 20463247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.
    Viviani MA; Cogliati M; Esposto MC; Lemmer K; Tintelnot K; Colom Valiente MF; Swinne D; Velegraki A; Velho R;
    FEMS Yeast Res; 2006 Jun; 6(4):614-9. PubMed ID: 16696657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of cryptococcosis.
    Ritter M; Goldman DL
    Expert Opin Pharmacother; 2009 Oct; 10(15):2433-43. PubMed ID: 19708853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.
    Calvo BM; Colombo AL; Fischman O; Santiago A; Thompson L; Lazera M; Telles F; Fukushima K; Nishimura K; Tanaka R; Myiajy M; Moretti-Branchini ML
    J Clin Microbiol; 2001 Jun; 39(6):2348-50. PubMed ID: 11376089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital.
    Shen YZ; Qi TK; Ma JX; Jiang XY; Wang JR; Xu QN; Huang Q; Liu XN; Sun HQ; Lu HZ
    Mycoses; 2007 Nov; 50(6):475-80. PubMed ID: 17944709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal lymphadenitis in HIV: a chance diagnosis by FNAC.
    Bhuyan P; Pattnaik K; Kar A; Brahma RC; Mahapatra S
    Diagn Cytopathol; 2013 May; 41(5):456-8. PubMed ID: 22508523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten challenges on Cryptococcus and cryptococcosis.
    Del Poeta M; Casadevall A
    Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.